nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—ALB—Vandetanib—thyroid cancer	0.139	0.619	CbGbCtD
Rufinamide—CES1—larynx—thyroid cancer	0.0475	0.247	CbGeAlD
Rufinamide—CYP3A4—Vandetanib—thyroid cancer	0.0437	0.194	CbGbCtD
Rufinamide—CYP3A4—Sorafenib—thyroid cancer	0.0263	0.117	CbGbCtD
Rufinamide—Balance disorder—Vandetanib—thyroid cancer	0.0205	0.036	CcSEcCtD
Rufinamide—CYP3A4—Doxorubicin—thyroid cancer	0.016	0.0709	CbGbCtD
Rufinamide—Nephrolithiasis—Vandetanib—thyroid cancer	0.0139	0.0245	CcSEcCtD
Rufinamide—GRM5—head—thyroid cancer	0.0135	0.0702	CbGeAlD
Rufinamide—Acne—Vandetanib—thyroid cancer	0.0133	0.0234	CcSEcCtD
Rufinamide—Gastrointestinal symptom NOS—Sorafenib—thyroid cancer	0.0128	0.0226	CcSEcCtD
Rufinamide—CES1—neck—thyroid cancer	0.0126	0.0655	CbGeAlD
Rufinamide—SCN11A—head—thyroid cancer	0.01	0.0521	CbGeAlD
Rufinamide—SCN7A—thyroid gland—thyroid cancer	0.0096	0.05	CbGeAlD
Rufinamide—SCN7A—head—thyroid cancer	0.00852	0.0443	CbGeAlD
Rufinamide—Bone disorder—Sorafenib—thyroid cancer	0.00836	0.0147	CcSEcCtD
Rufinamide—SCN8A—head—thyroid cancer	0.00759	0.0395	CbGeAlD
Rufinamide—Nasopharyngitis—Vandetanib—thyroid cancer	0.00727	0.0128	CcSEcCtD
Rufinamide—Influenza—Vandetanib—thyroid cancer	0.00703	0.0123	CcSEcCtD
Rufinamide—Bronchitis—Vandetanib—thyroid cancer	0.00676	0.0119	CcSEcCtD
Rufinamide—SCN4A—thyroid gland—thyroid cancer	0.00671	0.0349	CbGeAlD
Rufinamide—Neutropenia—Vandetanib—thyroid cancer	0.00657	0.0115	CcSEcCtD
Rufinamide—Dysuria—Vandetanib—thyroid cancer	0.00657	0.0115	CcSEcCtD
Rufinamide—Pollakiuria—Vandetanib—thyroid cancer	0.00649	0.0114	CcSEcCtD
Rufinamide—Weight decreased—Vandetanib—thyroid cancer	0.00636	0.0112	CcSEcCtD
Rufinamide—Pneumonia—Vandetanib—thyroid cancer	0.0063	0.0111	CcSEcCtD
Rufinamide—Infestation—Vandetanib—thyroid cancer	0.00627	0.011	CcSEcCtD
Rufinamide—Infestation NOS—Vandetanib—thyroid cancer	0.00627	0.011	CcSEcCtD
Rufinamide—CES1—thyroid gland—thyroid cancer	0.00599	0.0312	CbGeAlD
Rufinamide—Haematuria—Vandetanib—thyroid cancer	0.00597	0.0105	CcSEcCtD
Rufinamide—SCN7A—lymph node—thyroid cancer	0.00596	0.031	CbGeAlD
Rufinamide—SCN4A—head—thyroid cancer	0.00595	0.031	CbGeAlD
Rufinamide—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00593	0.0104	CcSEcCtD
Rufinamide—Epistaxis—Vandetanib—thyroid cancer	0.00591	0.0104	CcSEcCtD
Rufinamide—Sinusitis—Vandetanib—thyroid cancer	0.00588	0.0103	CcSEcCtD
Rufinamide—SCN1A—head—thyroid cancer	0.00574	0.0299	CbGeAlD
Rufinamide—Urinary tract disorder—Vandetanib—thyroid cancer	0.00555	0.00976	CcSEcCtD
Rufinamide—Urethral disorder—Vandetanib—thyroid cancer	0.00551	0.00968	CcSEcCtD
Rufinamide—CES1—head—thyroid cancer	0.00532	0.0277	CbGeAlD
Rufinamide—SCN2A—head—thyroid cancer	0.00527	0.0274	CbGeAlD
Rufinamide—Eye disorder—Vandetanib—thyroid cancer	0.00526	0.00923	CcSEcCtD
Rufinamide—Cardiac disorder—Vandetanib—thyroid cancer	0.00522	0.00917	CcSEcCtD
Rufinamide—SCN3A—thyroid gland—thyroid cancer	0.00522	0.0272	CbGeAlD
Rufinamide—SCN10A—head—thyroid cancer	0.00508	0.0264	CbGeAlD
Rufinamide—Mediastinal disorder—Vandetanib—thyroid cancer	0.00507	0.0089	CcSEcCtD
Rufinamide—Abdominal pain upper—Sorafenib—thyroid cancer	0.00501	0.0088	CcSEcCtD
Rufinamide—Breast disorder—Sorafenib—thyroid cancer	0.00496	0.00871	CcSEcCtD
Rufinamide—Mental disorder—Vandetanib—thyroid cancer	0.00493	0.00866	CcSEcCtD
Rufinamide—Nasopharyngitis—Sorafenib—thyroid cancer	0.0049	0.00861	CcSEcCtD
Rufinamide—Malnutrition—Vandetanib—thyroid cancer	0.0049	0.0086	CcSEcCtD
Rufinamide—SCN9A—lymph node—thyroid cancer	0.00467	0.0243	CbGeAlD
Rufinamide—SCN3A—head—thyroid cancer	0.00463	0.0241	CbGeAlD
Rufinamide—SCN5A—head—thyroid cancer	0.00462	0.024	CbGeAlD
Rufinamide—Vision blurred—Vandetanib—thyroid cancer	0.00461	0.0081	CcSEcCtD
Rufinamide—Tremor—Vandetanib—thyroid cancer	0.00459	0.00806	CcSEcCtD
Rufinamide—Neutropenia—Sorafenib—thyroid cancer	0.00443	0.00779	CcSEcCtD
Rufinamide—Weight decreased—Sorafenib—thyroid cancer	0.00429	0.00753	CcSEcCtD
Rufinamide—Pneumonia—Sorafenib—thyroid cancer	0.00425	0.00747	CcSEcCtD
Rufinamide—Convulsion—Vandetanib—thyroid cancer	0.00424	0.00745	CcSEcCtD
Rufinamide—Infestation—Sorafenib—thyroid cancer	0.00423	0.00742	CcSEcCtD
Rufinamide—Infestation NOS—Sorafenib—thyroid cancer	0.00423	0.00742	CcSEcCtD
Rufinamide—Anxiety—Vandetanib—thyroid cancer	0.00415	0.0073	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00414	0.00727	CcSEcCtD
Rufinamide—Hepatobiliary disease—Sorafenib—thyroid cancer	0.004	0.00702	CcSEcCtD
Rufinamide—Epistaxis—Sorafenib—thyroid cancer	0.00399	0.007	CcSEcCtD
Rufinamide—Infection—Vandetanib—thyroid cancer	0.00397	0.00697	CcSEcCtD
Rufinamide—Nervous system disorder—Vandetanib—thyroid cancer	0.00392	0.00688	CcSEcCtD
Rufinamide—Thrombocytopenia—Vandetanib—thyroid cancer	0.00391	0.00687	CcSEcCtD
Rufinamide—Nystagmus—Epirubicin—thyroid cancer	0.00391	0.00687	CcSEcCtD
Rufinamide—Skin disorder—Vandetanib—thyroid cancer	0.00388	0.00682	CcSEcCtD
Rufinamide—Urinary tract disorder—Sorafenib—thyroid cancer	0.00375	0.00658	CcSEcCtD
Rufinamide—CES1—lymph node—thyroid cancer	0.00372	0.0194	CbGeAlD
Rufinamide—Urethral disorder—Sorafenib—thyroid cancer	0.00372	0.00653	CcSEcCtD
Rufinamide—Nystagmus—Doxorubicin—thyroid cancer	0.00362	0.00635	CcSEcCtD
Rufinamide—Insomnia—Vandetanib—thyroid cancer	0.00361	0.00635	CcSEcCtD
Rufinamide—SCN10A—lymph node—thyroid cancer	0.00356	0.0185	CbGeAlD
Rufinamide—Cardiac disorder—Sorafenib—thyroid cancer	0.00352	0.00618	CcSEcCtD
Rufinamide—Dyspepsia—Vandetanib—thyroid cancer	0.00352	0.00618	CcSEcCtD
Rufinamide—Decreased appetite—Vandetanib—thyroid cancer	0.00347	0.0061	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00345	0.00606	CcSEcCtD
Rufinamide—Fatigue—Vandetanib—thyroid cancer	0.00344	0.00605	CcSEcCtD
Rufinamide—Immune system disorder—Sorafenib—thyroid cancer	0.00343	0.00602	CcSEcCtD
Rufinamide—Mediastinal disorder—Sorafenib—thyroid cancer	0.00342	0.00601	CcSEcCtD
Rufinamide—Constipation—Vandetanib—thyroid cancer	0.00342	0.006	CcSEcCtD
Rufinamide—Mental disorder—Sorafenib—thyroid cancer	0.00332	0.00584	CcSEcCtD
Rufinamide—Malnutrition—Sorafenib—thyroid cancer	0.0033	0.0058	CcSEcCtD
Rufinamide—SCN3A—lymph node—thyroid cancer	0.00324	0.0169	CbGeAlD
Rufinamide—Bone disorder—Epirubicin—thyroid cancer	0.00309	0.00543	CcSEcCtD
Rufinamide—Anaemia—Sorafenib—thyroid cancer	0.00305	0.00536	CcSEcCtD
Rufinamide—Nocturia—Epirubicin—thyroid cancer	0.00301	0.00529	CcSEcCtD
Rufinamide—Leukopenia—Sorafenib—thyroid cancer	0.00296	0.00519	CcSEcCtD
Rufinamide—Asthenia—Vandetanib—thyroid cancer	0.00287	0.00504	CcSEcCtD
Rufinamide—Gait disturbance—Epirubicin—thyroid cancer	0.00286	0.00502	CcSEcCtD
Rufinamide—Bone disorder—Doxorubicin—thyroid cancer	0.00286	0.00502	CcSEcCtD
Rufinamide—Coordination abnormal—Epirubicin—thyroid cancer	0.00284	0.00499	CcSEcCtD
Rufinamide—Pruritus—Vandetanib—thyroid cancer	0.00283	0.00497	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00279	0.0049	CcSEcCtD
Rufinamide—Nocturia—Doxorubicin—thyroid cancer	0.00278	0.00489	CcSEcCtD
Rufinamide—Diarrhoea—Vandetanib—thyroid cancer	0.00273	0.0048	CcSEcCtD
Rufinamide—Infection—Sorafenib—thyroid cancer	0.00268	0.0047	CcSEcCtD
Rufinamide—Gait disturbance—Doxorubicin—thyroid cancer	0.00265	0.00465	CcSEcCtD
Rufinamide—Nervous system disorder—Sorafenib—thyroid cancer	0.00264	0.00464	CcSEcCtD
Rufinamide—Dizziness—Vandetanib—thyroid cancer	0.00264	0.00464	CcSEcCtD
Rufinamide—Thrombocytopenia—Sorafenib—thyroid cancer	0.00264	0.00464	CcSEcCtD
Rufinamide—Coordination abnormal—Doxorubicin—thyroid cancer	0.00263	0.00462	CcSEcCtD
Rufinamide—Skin disorder—Sorafenib—thyroid cancer	0.00262	0.0046	CcSEcCtD
Rufinamide—ALB—lymph node—thyroid cancer	0.00259	0.0135	CbGeAlD
Rufinamide—Anorexia—Sorafenib—thyroid cancer	0.00257	0.00451	CcSEcCtD
Rufinamide—Vomiting—Vandetanib—thyroid cancer	0.00254	0.00446	CcSEcCtD
Rufinamide—Rash—Vandetanib—thyroid cancer	0.00252	0.00443	CcSEcCtD
Rufinamide—Dermatitis—Vandetanib—thyroid cancer	0.00252	0.00442	CcSEcCtD
Rufinamide—Headache—Vandetanib—thyroid cancer	0.0025	0.0044	CcSEcCtD
Rufinamide—CYP2E1—thyroid gland—thyroid cancer	0.00246	0.0128	CbGeAlD
Rufinamide—Lymphadenopathy—Epirubicin—thyroid cancer	0.00238	0.00417	CcSEcCtD
Rufinamide—Nausea—Vandetanib—thyroid cancer	0.00237	0.00417	CcSEcCtD
Rufinamide—Dyspepsia—Sorafenib—thyroid cancer	0.00237	0.00417	CcSEcCtD
Rufinamide—Decreased appetite—Sorafenib—thyroid cancer	0.00234	0.00412	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00233	0.00409	CcSEcCtD
Rufinamide—Fatigue—Sorafenib—thyroid cancer	0.00232	0.00408	CcSEcCtD
Rufinamide—Constipation—Sorafenib—thyroid cancer	0.0023	0.00405	CcSEcCtD
Rufinamide—Lymphadenopathy—Doxorubicin—thyroid cancer	0.0022	0.00386	CcSEcCtD
Rufinamide—CYP2E1—head—thyroid cancer	0.00219	0.0114	CbGeAlD
Rufinamide—Increased appetite—Epirubicin—thyroid cancer	0.00216	0.00379	CcSEcCtD
Rufinamide—Diplopia—Epirubicin—thyroid cancer	0.00203	0.00356	CcSEcCtD
Rufinamide—Increased appetite—Doxorubicin—thyroid cancer	0.002	0.00351	CcSEcCtD
Rufinamide—Hypersensitivity—Sorafenib—thyroid cancer	0.00199	0.00349	CcSEcCtD
Rufinamide—Asthenia—Sorafenib—thyroid cancer	0.00193	0.0034	CcSEcCtD
Rufinamide—Pruritus—Sorafenib—thyroid cancer	0.00191	0.00335	CcSEcCtD
Rufinamide—Ataxia—Epirubicin—thyroid cancer	0.00191	0.00335	CcSEcCtD
Rufinamide—Diplopia—Doxorubicin—thyroid cancer	0.00188	0.00329	CcSEcCtD
Rufinamide—Abdominal pain upper—Epirubicin—thyroid cancer	0.00185	0.00325	CcSEcCtD
Rufinamide—Diarrhoea—Sorafenib—thyroid cancer	0.00184	0.00324	CcSEcCtD
Rufinamide—Breast disorder—Epirubicin—thyroid cancer	0.00183	0.00322	CcSEcCtD
Rufinamide—Nasopharyngitis—Epirubicin—thyroid cancer	0.00181	0.00318	CcSEcCtD
Rufinamide—Dizziness—Sorafenib—thyroid cancer	0.00178	0.00313	CcSEcCtD
Rufinamide—Ataxia—Doxorubicin—thyroid cancer	0.00176	0.0031	CcSEcCtD
Rufinamide—Influenza—Epirubicin—thyroid cancer	0.00175	0.00308	CcSEcCtD
Rufinamide—Vomiting—Sorafenib—thyroid cancer	0.00171	0.00301	CcSEcCtD
Rufinamide—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00171	0.00301	CcSEcCtD
Rufinamide—Rash—Sorafenib—thyroid cancer	0.0017	0.00299	CcSEcCtD
Rufinamide—Dermatitis—Sorafenib—thyroid cancer	0.0017	0.00298	CcSEcCtD
Rufinamide—Breast disorder—Doxorubicin—thyroid cancer	0.00169	0.00298	CcSEcCtD
Rufinamide—Headache—Sorafenib—thyroid cancer	0.00169	0.00297	CcSEcCtD
Rufinamide—Bronchitis—Epirubicin—thyroid cancer	0.00168	0.00296	CcSEcCtD
Rufinamide—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00168	0.00295	CcSEcCtD
Rufinamide—Dysuria—Epirubicin—thyroid cancer	0.00164	0.00288	CcSEcCtD
Rufinamide—Neutropenia—Epirubicin—thyroid cancer	0.00164	0.00288	CcSEcCtD
Rufinamide—Influenza—Doxorubicin—thyroid cancer	0.00162	0.00285	CcSEcCtD
Rufinamide—Pollakiuria—Epirubicin—thyroid cancer	0.00162	0.00284	CcSEcCtD
Rufinamide—Nausea—Sorafenib—thyroid cancer	0.0016	0.00281	CcSEcCtD
Rufinamide—Weight decreased—Epirubicin—thyroid cancer	0.00158	0.00278	CcSEcCtD
Rufinamide—Pneumonia—Epirubicin—thyroid cancer	0.00157	0.00276	CcSEcCtD
Rufinamide—Infestation NOS—Epirubicin—thyroid cancer	0.00156	0.00274	CcSEcCtD
Rufinamide—Infestation—Epirubicin—thyroid cancer	0.00156	0.00274	CcSEcCtD
Rufinamide—Bronchitis—Doxorubicin—thyroid cancer	0.00156	0.00274	CcSEcCtD
Rufinamide—Dysuria—Doxorubicin—thyroid cancer	0.00152	0.00266	CcSEcCtD
Rufinamide—Neutropenia—Doxorubicin—thyroid cancer	0.00152	0.00266	CcSEcCtD
Rufinamide—Pollakiuria—Doxorubicin—thyroid cancer	0.0015	0.00263	CcSEcCtD
Rufinamide—Haematuria—Epirubicin—thyroid cancer	0.00149	0.00262	CcSEcCtD
Rufinamide—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00148	0.00259	CcSEcCtD
Rufinamide—Epistaxis—Epirubicin—thyroid cancer	0.00147	0.00259	CcSEcCtD
Rufinamide—Weight decreased—Doxorubicin—thyroid cancer	0.00147	0.00258	CcSEcCtD
Rufinamide—Sinusitis—Epirubicin—thyroid cancer	0.00147	0.00257	CcSEcCtD
Rufinamide—Pneumonia—Doxorubicin—thyroid cancer	0.00145	0.00255	CcSEcCtD
Rufinamide—Infestation NOS—Doxorubicin—thyroid cancer	0.00145	0.00254	CcSEcCtD
Rufinamide—Infestation—Doxorubicin—thyroid cancer	0.00145	0.00254	CcSEcCtD
Rufinamide—Rhinitis—Epirubicin—thyroid cancer	0.00141	0.00247	CcSEcCtD
Rufinamide—Urinary tract disorder—Epirubicin—thyroid cancer	0.00138	0.00243	CcSEcCtD
Rufinamide—Haematuria—Doxorubicin—thyroid cancer	0.00138	0.00242	CcSEcCtD
Rufinamide—Urethral disorder—Epirubicin—thyroid cancer	0.00137	0.00241	CcSEcCtD
Rufinamide—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00137	0.0024	CcSEcCtD
Rufinamide—Epistaxis—Doxorubicin—thyroid cancer	0.00136	0.00239	CcSEcCtD
Rufinamide—Sinusitis—Doxorubicin—thyroid cancer	0.00136	0.00238	CcSEcCtD
Rufinamide—Eye disorder—Epirubicin—thyroid cancer	0.00131	0.0023	CcSEcCtD
Rufinamide—Cardiac disorder—Epirubicin—thyroid cancer	0.0013	0.00229	CcSEcCtD
Rufinamide—Rhinitis—Doxorubicin—thyroid cancer	0.0013	0.00228	CcSEcCtD
Rufinamide—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00128	0.00225	CcSEcCtD
Rufinamide—Urethral disorder—Doxorubicin—thyroid cancer	0.00127	0.00223	CcSEcCtD
Rufinamide—Immune system disorder—Epirubicin—thyroid cancer	0.00127	0.00222	CcSEcCtD
Rufinamide—Mediastinal disorder—Epirubicin—thyroid cancer	0.00126	0.00222	CcSEcCtD
Rufinamide—Mental disorder—Epirubicin—thyroid cancer	0.00123	0.00216	CcSEcCtD
Rufinamide—Malnutrition—Epirubicin—thyroid cancer	0.00122	0.00214	CcSEcCtD
Rufinamide—Eye disorder—Doxorubicin—thyroid cancer	0.00121	0.00213	CcSEcCtD
Rufinamide—Cardiac disorder—Doxorubicin—thyroid cancer	0.0012	0.00211	CcSEcCtD
Rufinamide—Back pain—Epirubicin—thyroid cancer	0.00118	0.00207	CcSEcCtD
Rufinamide—Immune system disorder—Doxorubicin—thyroid cancer	0.00117	0.00206	CcSEcCtD
Rufinamide—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00117	0.00205	CcSEcCtD
Rufinamide—Vision blurred—Epirubicin—thyroid cancer	0.00115	0.00202	CcSEcCtD
Rufinamide—Mental disorder—Doxorubicin—thyroid cancer	0.00114	0.002	CcSEcCtD
Rufinamide—Malnutrition—Doxorubicin—thyroid cancer	0.00113	0.00198	CcSEcCtD
Rufinamide—Anaemia—Epirubicin—thyroid cancer	0.00113	0.00198	CcSEcCtD
Rufinamide—Agitation—Epirubicin—thyroid cancer	0.00112	0.00197	CcSEcCtD
Rufinamide—Vertigo—Epirubicin—thyroid cancer	0.0011	0.00193	CcSEcCtD
Rufinamide—Leukopenia—Epirubicin—thyroid cancer	0.00109	0.00192	CcSEcCtD
Rufinamide—Back pain—Doxorubicin—thyroid cancer	0.00109	0.00192	CcSEcCtD
Rufinamide—Vision blurred—Doxorubicin—thyroid cancer	0.00106	0.00187	CcSEcCtD
Rufinamide—Convulsion—Epirubicin—thyroid cancer	0.00106	0.00186	CcSEcCtD
Rufinamide—Anaemia—Doxorubicin—thyroid cancer	0.00104	0.00183	CcSEcCtD
Rufinamide—Agitation—Doxorubicin—thyroid cancer	0.00104	0.00182	CcSEcCtD
Rufinamide—Anxiety—Epirubicin—thyroid cancer	0.00104	0.00182	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00103	0.00181	CcSEcCtD
Rufinamide—Vertigo—Doxorubicin—thyroid cancer	0.00101	0.00178	CcSEcCtD
Rufinamide—Leukopenia—Doxorubicin—thyroid cancer	0.00101	0.00178	CcSEcCtD
Rufinamide—Infection—Epirubicin—thyroid cancer	0.00099	0.00174	CcSEcCtD
Rufinamide—Convulsion—Doxorubicin—thyroid cancer	0.000979	0.00172	CcSEcCtD
Rufinamide—Nervous system disorder—Epirubicin—thyroid cancer	0.000977	0.00172	CcSEcCtD
Rufinamide—Thrombocytopenia—Epirubicin—thyroid cancer	0.000975	0.00171	CcSEcCtD
Rufinamide—Skin disorder—Epirubicin—thyroid cancer	0.000968	0.0017	CcSEcCtD
Rufinamide—Anxiety—Doxorubicin—thyroid cancer	0.000958	0.00168	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000955	0.00168	CcSEcCtD
Rufinamide—Anorexia—Epirubicin—thyroid cancer	0.00095	0.00167	CcSEcCtD
Rufinamide—Infection—Doxorubicin—thyroid cancer	0.000916	0.00161	CcSEcCtD
Rufinamide—Nervous system disorder—Doxorubicin—thyroid cancer	0.000904	0.00159	CcSEcCtD
Rufinamide—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000902	0.00159	CcSEcCtD
Rufinamide—Insomnia—Epirubicin—thyroid cancer	0.000901	0.00158	CcSEcCtD
Rufinamide—Skin disorder—Doxorubicin—thyroid cancer	0.000895	0.00157	CcSEcCtD
Rufinamide—Somnolence—Epirubicin—thyroid cancer	0.000886	0.00156	CcSEcCtD
Rufinamide—Anorexia—Doxorubicin—thyroid cancer	0.000879	0.00154	CcSEcCtD
Rufinamide—Dyspepsia—Epirubicin—thyroid cancer	0.000877	0.00154	CcSEcCtD
Rufinamide—Decreased appetite—Epirubicin—thyroid cancer	0.000866	0.00152	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00086	0.00151	CcSEcCtD
Rufinamide—Fatigue—Epirubicin—thyroid cancer	0.000859	0.00151	CcSEcCtD
Rufinamide—Constipation—Epirubicin—thyroid cancer	0.000852	0.0015	CcSEcCtD
Rufinamide—Insomnia—Doxorubicin—thyroid cancer	0.000834	0.00146	CcSEcCtD
Rufinamide—Somnolence—Doxorubicin—thyroid cancer	0.000819	0.00144	CcSEcCtD
Rufinamide—Dyspepsia—Doxorubicin—thyroid cancer	0.000811	0.00143	CcSEcCtD
Rufinamide—Decreased appetite—Doxorubicin—thyroid cancer	0.000801	0.00141	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000796	0.0014	CcSEcCtD
Rufinamide—Fatigue—Doxorubicin—thyroid cancer	0.000795	0.0014	CcSEcCtD
Rufinamide—Constipation—Doxorubicin—thyroid cancer	0.000788	0.00138	CcSEcCtD
Rufinamide—Hypersensitivity—Epirubicin—thyroid cancer	0.000734	0.00129	CcSEcCtD
Rufinamide—Asthenia—Epirubicin—thyroid cancer	0.000715	0.00126	CcSEcCtD
Rufinamide—Pruritus—Epirubicin—thyroid cancer	0.000705	0.00124	CcSEcCtD
Rufinamide—Diarrhoea—Epirubicin—thyroid cancer	0.000682	0.0012	CcSEcCtD
Rufinamide—Hypersensitivity—Doxorubicin—thyroid cancer	0.000679	0.00119	CcSEcCtD
Rufinamide—Asthenia—Doxorubicin—thyroid cancer	0.000661	0.00116	CcSEcCtD
Rufinamide—Dizziness—Epirubicin—thyroid cancer	0.000659	0.00116	CcSEcCtD
Rufinamide—Pruritus—Doxorubicin—thyroid cancer	0.000652	0.00115	CcSEcCtD
Rufinamide—Vomiting—Epirubicin—thyroid cancer	0.000633	0.00111	CcSEcCtD
Rufinamide—Diarrhoea—Doxorubicin—thyroid cancer	0.000631	0.00111	CcSEcCtD
Rufinamide—Rash—Epirubicin—thyroid cancer	0.000628	0.0011	CcSEcCtD
Rufinamide—Dermatitis—Epirubicin—thyroid cancer	0.000628	0.0011	CcSEcCtD
Rufinamide—Headache—Epirubicin—thyroid cancer	0.000624	0.0011	CcSEcCtD
Rufinamide—Dizziness—Doxorubicin—thyroid cancer	0.00061	0.00107	CcSEcCtD
Rufinamide—CES1—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.000598	0.0449	CbGpPWpGaD
Rufinamide—Nausea—Epirubicin—thyroid cancer	0.000592	0.00104	CcSEcCtD
Rufinamide—Vomiting—Doxorubicin—thyroid cancer	0.000586	0.00103	CcSEcCtD
Rufinamide—Rash—Doxorubicin—thyroid cancer	0.000581	0.00102	CcSEcCtD
Rufinamide—Dermatitis—Doxorubicin—thyroid cancer	0.000581	0.00102	CcSEcCtD
Rufinamide—Headache—Doxorubicin—thyroid cancer	0.000577	0.00101	CcSEcCtD
Rufinamide—Nausea—Doxorubicin—thyroid cancer	0.000547	0.000962	CcSEcCtD
Rufinamide—GRM5—GPCR ligand binding—CALCB—thyroid cancer	0.000411	0.0308	CbGpPWpGaD
Rufinamide—CES1—E2F transcription factor network—CDK1—thyroid cancer	0.000306	0.023	CbGpPWpGaD
Rufinamide—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.000257	0.0193	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—RET—thyroid cancer	0.000254	0.0191	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.000236	0.0177	CbGpPWpGaD
Rufinamide—ALB—Recycling of bile acids and salts—RXRA—thyroid cancer	0.000234	0.0176	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—CALCB—thyroid cancer	0.000232	0.0174	CbGpPWpGaD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—CDK1—thyroid cancer	0.000229	0.0172	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—CALCB—thyroid cancer	0.000211	0.0158	CbGpPWpGaD
Rufinamide—SCN5A—Cardiac Progenitor Differentiation—NRG1—thyroid cancer	0.000206	0.0155	CbGpPWpGaD
Rufinamide—CES1—NRF2 pathway—SLC5A5—thyroid cancer	0.000194	0.0146	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—TSHR—thyroid cancer	0.00019	0.0143	CbGpPWpGaD
Rufinamide—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000184	0.0138	CbGpPWpGaD
Rufinamide—CES1—NRF2 pathway—RXRA—thyroid cancer	0.000163	0.0123	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—PTCH1—thyroid cancer	0.000162	0.0121	CbGpPWpGaD
Rufinamide—CES1—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000159	0.0119	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.000157	0.0118	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—SST—thyroid cancer	0.000148	0.0111	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—CDK1—thyroid cancer	0.000147	0.011	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—CALCA—thyroid cancer	0.000142	0.0107	CbGpPWpGaD
Rufinamide—CES1—NRF2 pathway—NRG1—thyroid cancer	0.000141	0.0106	CbGpPWpGaD
Rufinamide—CYP2E1—Metapathway biotransformation—CHST14—thyroid cancer	0.000138	0.0104	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—CDK1—thyroid cancer	0.000131	0.00982	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CALCB—thyroid cancer	0.000125	0.00935	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000124	0.00932	CbGpPWpGaD
Rufinamide—CYP2E1—Vitamin A and Carotenoid Metabolism—RXRA—thyroid cancer	0.000124	0.00927	CbGpPWpGaD
Rufinamide—ALB—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.000122	0.00918	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—CDK1—thyroid cancer	0.00012	0.00898	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TRIM33—thyroid cancer	0.000118	0.00886	CbGpPWpGaD
Rufinamide—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.00011	0.00827	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—TSHR—thyroid cancer	0.000107	0.00807	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—CDK1—thyroid cancer	0.000105	0.00786	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—TSHR—thyroid cancer	9.76e-05	0.00733	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—RXRA—thyroid cancer	9.72e-05	0.0073	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—CDK1—thyroid cancer	9.67e-05	0.00726	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—PRKAR1A—thyroid cancer	9.6e-05	0.00721	CbGpPWpGaD
Rufinamide—CYP2E1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	9.46e-05	0.0071	CbGpPWpGaD
Rufinamide—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	9.41e-05	0.00706	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—CDK1—thyroid cancer	9.33e-05	0.00701	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—CDK1—thyroid cancer	9.25e-05	0.00695	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—CDK1—thyroid cancer	8.89e-05	0.00667	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—CDK1—thyroid cancer	8.89e-05	0.00667	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—RXRA—thyroid cancer	8.66e-05	0.0065	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—CDK1—thyroid cancer	8.57e-05	0.00643	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—CDK1—thyroid cancer	8.57e-05	0.00643	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—CDK1—thyroid cancer	8.54e-05	0.00641	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—SST—thyroid cancer	8.36e-05	0.00627	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—PTCH1—thyroid cancer	8.3e-05	0.00623	CbGpPWpGaD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	8.2e-05	0.00615	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—CALCA—thyroid cancer	8.05e-05	0.00604	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—RXRA—thyroid cancer	7.92e-05	0.00595	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TCF7L1—thyroid cancer	7.88e-05	0.00591	CbGpPWpGaD
Rufinamide—CYP2E1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	7.67e-05	0.00576	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—SST—thyroid cancer	7.59e-05	0.0057	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	7.45e-05	0.00559	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—CALCA—thyroid cancer	7.31e-05	0.00548	CbGpPWpGaD
Rufinamide—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	7.26e-05	0.00545	CbGpPWpGaD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	7.06e-05	0.0053	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—CDK1—thyroid cancer	6.9e-05	0.00518	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—CDK1—thyroid cancer	6.61e-05	0.00496	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—CDK1—thyroid cancer	6.6e-05	0.00496	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—RXRA—thyroid cancer	6.41e-05	0.00481	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	6.4e-05	0.00481	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—CDK1—thyroid cancer	6.34e-05	0.00476	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—CDK1—thyroid cancer	6.34e-05	0.00476	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—PPARG—thyroid cancer	6.14e-05	0.00461	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—RXRA—thyroid cancer	6.13e-05	0.0046	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—CDK1—thyroid cancer	6.12e-05	0.00459	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—CDK1—thyroid cancer	6.12e-05	0.00459	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—CDK1—thyroid cancer	6.03e-05	0.00452	CbGpPWpGaD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	6e-05	0.0045	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—RXRA—thyroid cancer	5.89e-05	0.00442	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—RXRA—thyroid cancer	5.89e-05	0.00442	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TSHR—thyroid cancer	5.77e-05	0.00433	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—RXRA—thyroid cancer	5.68e-05	0.00426	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—RXRA—thyroid cancer	5.68e-05	0.00426	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PRKAR1A—thyroid cancer	5.67e-05	0.00426	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—PPARG—thyroid cancer	5.47e-05	0.00411	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MEN1—thyroid cancer	5.42e-05	0.00407	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—NRAS—thyroid cancer	5.26e-05	0.00395	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—PPARG—thyroid cancer	5e-05	0.00375	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PTCH1—thyroid cancer	4.9e-05	0.00368	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—NRAS—thyroid cancer	4.69e-05	0.00352	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—KRAS—thyroid cancer	4.53e-05	0.0034	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SST—thyroid cancer	4.48e-05	0.00337	CbGpPWpGaD
Rufinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	4.39e-05	0.00329	CbGpPWpGaD
Rufinamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	4.37e-05	0.00328	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CALCA—thyroid cancer	4.32e-05	0.00324	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—CDK1—thyroid cancer	4.3e-05	0.00323	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—NRAS—thyroid cancer	4.29e-05	0.00322	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—RXRA—thyroid cancer	4.07e-05	0.00306	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—PPARG—thyroid cancer	4.05e-05	0.00304	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—KRAS—thyroid cancer	4.04e-05	0.00303	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—CP—thyroid cancer	4e-05	0.003	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—TPR—thyroid cancer	4e-05	0.003	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—RXRA—thyroid cancer	3.99e-05	0.003	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CDK1—thyroid cancer	3.91e-05	0.00293	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—PPARG—thyroid cancer	3.87e-05	0.0029	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—HRAS—thyroid cancer	3.85e-05	0.00289	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—NRAS—thyroid cancer	3.76e-05	0.00282	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	3.72e-05	0.00279	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—PPARG—thyroid cancer	3.72e-05	0.00279	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—PPARG—thyroid cancer	3.72e-05	0.00279	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—KRAS—thyroid cancer	3.69e-05	0.00277	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—PPARG—thyroid cancer	3.59e-05	0.00269	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—PPARG—thyroid cancer	3.59e-05	0.00269	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	3.56e-05	0.00267	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—NRAS—thyroid cancer	3.47e-05	0.0026	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—HRAS—thyroid cancer	3.43e-05	0.00258	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—NRAS—thyroid cancer	3.35e-05	0.00251	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—NRAS—thyroid cancer	3.32e-05	0.00249	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—KRAS—thyroid cancer	3.23e-05	0.00243	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—NRAS—thyroid cancer	3.19e-05	0.00239	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—NRAS—thyroid cancer	3.19e-05	0.00239	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—HRAS—thyroid cancer	3.14e-05	0.00236	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NRG1—thyroid cancer	3.14e-05	0.00235	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—NRAS—thyroid cancer	3.08e-05	0.00231	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—NRAS—thyroid cancer	3.08e-05	0.00231	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—NRAS—thyroid cancer	3.06e-05	0.0023	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	2.99e-05	0.00225	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MINPP1—thyroid cancer	2.99e-05	0.00225	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—KRAS—thyroid cancer	2.99e-05	0.00224	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	2.97e-05	0.00223	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—KRAS—thyroid cancer	2.88e-05	0.00216	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—KRAS—thyroid cancer	2.86e-05	0.00214	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TERT—thyroid cancer	2.82e-05	0.00211	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—HRAS—thyroid cancer	2.75e-05	0.00206	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—KRAS—thyroid cancer	2.74e-05	0.00206	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—KRAS—thyroid cancer	2.74e-05	0.00206	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HIF1A—thyroid cancer	2.69e-05	0.00202	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—KRAS—thyroid cancer	2.65e-05	0.00199	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—KRAS—thyroid cancer	2.65e-05	0.00199	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—KRAS—thyroid cancer	2.64e-05	0.00198	CbGpPWpGaD
Rufinamide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	2.6e-05	0.00195	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MINPP1—thyroid cancer	2.57e-05	0.00193	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NDUFA13—thyroid cancer	2.55e-05	0.00191	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—HRAS—thyroid cancer	2.54e-05	0.00191	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—PPARG—thyroid cancer	2.52e-05	0.00189	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—NRAS—thyroid cancer	2.48e-05	0.00186	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—HRAS—thyroid cancer	2.45e-05	0.00184	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—HRAS—thyroid cancer	2.43e-05	0.00182	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—AKT1—thyroid cancer	2.43e-05	0.00182	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CHST14—thyroid cancer	2.39e-05	0.0018	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—NRAS—thyroid cancer	2.37e-05	0.00178	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—NRAS—thyroid cancer	2.37e-05	0.00178	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—HRAS—thyroid cancer	2.33e-05	0.00175	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—HRAS—thyroid cancer	2.33e-05	0.00175	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PRKAR1A—thyroid cancer	2.31e-05	0.00173	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—NRAS—thyroid cancer	2.28e-05	0.00171	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—NRAS—thyroid cancer	2.28e-05	0.00171	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—HRAS—thyroid cancer	2.25e-05	0.00169	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—HRAS—thyroid cancer	2.25e-05	0.00169	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—HRAS—thyroid cancer	2.24e-05	0.00168	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—BRAF—thyroid cancer	2.23e-05	0.00167	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TP53—thyroid cancer	2.23e-05	0.00167	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—NRAS—thyroid cancer	2.19e-05	0.00165	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—NRAS—thyroid cancer	2.19e-05	0.00165	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NDUFA13—thyroid cancer	2.19e-05	0.00164	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—AKT1—thyroid cancer	2.16e-05	0.00162	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—NRAS—thyroid cancer	2.16e-05	0.00162	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—KRAS—thyroid cancer	2.13e-05	0.0016	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CHST14—thyroid cancer	2.06e-05	0.00154	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—KRAS—thyroid cancer	2.04e-05	0.00153	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—KRAS—thyroid cancer	2.04e-05	0.00153	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	2.03e-05	0.00153	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	2.03e-05	0.00153	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2e-05	0.0015	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—AKT1—thyroid cancer	1.98e-05	0.00148	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—KRAS—thyroid cancer	1.96e-05	0.00147	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—KRAS—thyroid cancer	1.96e-05	0.00147	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HPGD—thyroid cancer	1.93e-05	0.00145	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—RXRA—thyroid cancer	1.89e-05	0.00142	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—KRAS—thyroid cancer	1.89e-05	0.00142	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—KRAS—thyroid cancer	1.89e-05	0.00142	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—KRAS—thyroid cancer	1.86e-05	0.0014	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—HRAS—thyroid cancer	1.81e-05	0.00136	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—HRAS—thyroid cancer	1.74e-05	0.0013	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—HRAS—thyroid cancer	1.73e-05	0.0013	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—AKT1—thyroid cancer	1.69e-05	0.00127	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—HRAS—thyroid cancer	1.66e-05	0.00125	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—HRAS—thyroid cancer	1.66e-05	0.00125	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HPGD—thyroid cancer	1.66e-05	0.00124	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CCND1—thyroid cancer	1.63e-05	0.00122	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—HRAS—thyroid cancer	1.61e-05	0.0012	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—HRAS—thyroid cancer	1.61e-05	0.0012	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—AKT1—thyroid cancer	1.6e-05	0.0012	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—HRAS—thyroid cancer	1.58e-05	0.00119	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PTEN—thyroid cancer	1.57e-05	0.00118	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—NRAS—thyroid cancer	1.54e-05	0.00116	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—AKT1—thyroid cancer	1.53e-05	0.00115	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IFNA2—thyroid cancer	1.53e-05	0.00115	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—AKT1—thyroid cancer	1.53e-05	0.00115	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.52e-05	0.00114	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—AKT1—thyroid cancer	1.47e-05	0.0011	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—AKT1—thyroid cancer	1.47e-05	0.0011	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—AKT1—thyroid cancer	1.42e-05	0.00106	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—AKT1—thyroid cancer	1.42e-05	0.00106	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NRAS—thyroid cancer	1.4e-05	0.00105	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MINPP1—thyroid cancer	1.39e-05	0.00104	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.34e-05	0.00101	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—KRAS—thyroid cancer	1.33e-05	0.000997	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.28e-05	0.00096	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—KRAS—thyroid cancer	1.21e-05	0.000905	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.18e-05	0.000886	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—HRAS—thyroid cancer	1.13e-05	0.000847	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CHST14—thyroid cancer	1.11e-05	0.000833	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TPR—thyroid cancer	1.11e-05	0.000832	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	1.09e-05	0.000818	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TP53—thyroid cancer	1.07e-05	0.000805	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HRAS—thyroid cancer	1.03e-05	0.00077	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—AKT1—thyroid cancer	9.97e-06	0.000748	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TPR—thyroid cancer	9.52e-06	0.000715	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PRKAR1A—thyroid cancer	9.37e-06	0.000703	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—AKT1—thyroid cancer	9.05e-06	0.00068	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HPGD—thyroid cancer	8.95e-06	0.000672	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	8.49e-06	0.000637	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC5A5—thyroid cancer	8.29e-06	0.000622	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	7.15e-06	0.000537	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC5A5—thyroid cancer	7.13e-06	0.000535	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—RXRA—thyroid cancer	6.97e-06	0.000523	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.68e-06	0.000501	CbGpPWpGaD
Rufinamide—ALB—Metabolism—RXRA—thyroid cancer	5.99e-06	0.000449	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.82e-06	0.000437	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NRAS—thyroid cancer	5.71e-06	0.000428	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TPR—thyroid cancer	5.14e-06	0.000386	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	5.06e-06	0.00038	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—KRAS—thyroid cancer	4.91e-06	0.000369	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPARG—thyroid cancer	4.4e-06	0.00033	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TP53—thyroid cancer	4.37e-06	0.000328	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HRAS—thyroid cancer	4.18e-06	0.000313	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC5A5—thyroid cancer	3.85e-06	0.000289	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPARG—thyroid cancer	3.78e-06	0.000284	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT1—thyroid cancer	3.69e-06	0.000277	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTGS2—thyroid cancer	3.46e-06	0.00026	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—RXRA—thyroid cancer	3.23e-06	0.000243	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTEN—thyroid cancer	3.02e-06	0.000227	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTGS2—thyroid cancer	2.97e-06	0.000223	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTEN—thyroid cancer	2.59e-06	0.000195	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPARG—thyroid cancer	2.04e-06	0.000153	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKT1—thyroid cancer	1.74e-06	0.000131	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.61e-06	0.000121	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKT1—thyroid cancer	1.49e-06	0.000112	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTEN—thyroid cancer	1.4e-06	0.000105	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKT1—thyroid cancer	8.07e-07	6.06e-05	CbGpPWpGaD
